» Articles » PMID: 16982810

Impaired Selection of Invariant Natural Killer T Cells in Diverse Mouse Models of Glycosphingolipid Lysosomal Storage Diseases

Overview
Journal J Exp Med
Date 2006 Sep 20
PMID 16982810
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Glycolipid ligands for invariant natural killer T cells (iNKT cells) are loaded onto CD1d molecules in the late endosome/lysosome. Accumulation of glycosphingolipids (GSLs) in lysosomal storage diseases could potentially influence endogenous and exogenous lipid loading and/or presentation and, thus, affect iNKT cell selection or function. The percentages and frequency of iNKT cells were reduced in multiple mouse models of lysosomal GSL storage disease, irrespective of the specific genetic defect or lipid species stored. Reduced numbers of iNKT cells resulted in the absence of cytokine production in response to alpha-galactosylceramide (alpha-GalCer) and reduced iNKT cell-mediated lysis of wild-type targets loaded with alpha-GalCer. The reduction in iNKT cells did not result from defective expression of CD1d or a lack of antigen-presenting cells. Although H-2 restricted CD4(+) T cell responses were generally unaffected, processing of a lysosome-dependent analogue of alpha-GalCer was impaired in all the strains of mice tested. These data suggest that GSL storage may result in alterations in thymic selection of iNKT cells caused by impaired presentation of selecting ligands.

Citing Articles

Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms.

Magnusen A, Pandey M Int J Mol Sci. 2024; 25(22).

PMID: 39596318 PMC: 11594573. DOI: 10.3390/ijms252212252.


The surveillance of viral infections by the unconventional Type I NKT cell.

Rajashekar V, Stern L, Almeida C, Slobedman B, Abendroth A Front Immunol. 2024; 15:1472854.

PMID: 39355244 PMC: 11442276. DOI: 10.3389/fimmu.2024.1472854.


Inherited Metabolic Disorders: From Bench to Bedside.

Fonseca T, Macedo M Biomedicines. 2024; 12(1).

PMID: 38255278 PMC: 10813142. DOI: 10.3390/biomedicines12010174.


Leukocyte Imbalances in Mucopolysaccharidoses Patients.

Lopes N, Maia M, Pereira C, Mondragao-Rodrigues I, Martins E, Ribeiro R Biomedicines. 2023; 11(6).

PMID: 37371793 PMC: 10296078. DOI: 10.3390/biomedicines11061699.


Glycolipids in Parkinson's disease: beyond neuronal function.

Spanos F, Deleidi M FEBS Open Bio. 2023; 13(9):1558-1579.

PMID: 37219461 PMC: 10476577. DOI: 10.1002/2211-5463.13651.


References
1.
Park S, Benlagha K, Lee D, Balish E, Bendelac A . Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice. Eur J Immunol. 2000; 30(2):620-5. DOI: 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4. View

2.
Schuette C, Doering T, Kolter T, Sandhoff K . The glycosphingolipidoses-from disease to basic principles of metabolism. Biol Chem. 1999; 380(7-8):759-66. DOI: 10.1515/BC.1999.096. View

3.
Prigozy T, Naidenko O, Qasba P, Elewaut D, Brossay L, Khurana A . Glycolipid antigen processing for presentation by CD1d molecules. Science. 2001; 291(5504):664-7. DOI: 10.1126/science.291.5504.664. View

4.
Karadimitris A, Gadola S, Altamirano M, Brown D, Woolfson A, Klenerman P . Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci U S A. 2001; 98(6):3294-8. PMC: 30647. DOI: 10.1073/pnas.051604498. View

5.
Gapin L, Matsuda J, Surh C, Kronenberg M . NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol. 2001; 2(10):971-8. DOI: 10.1038/ni710. View